Yaorui Sun, Shujiao Liu, Wenli Si, Quanyi Zhang, Fei Yu, Ming Su, Chao Sun
{"title":"酒石酸丁吗啡诺在不同年龄段无痛胃镜检查患者中的有效剂量。","authors":"Yaorui Sun, Shujiao Liu, Wenli Si, Quanyi Zhang, Fei Yu, Ming Su, Chao Sun","doi":"10.1177/03000605241277689","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study evaluated the 50% effective dose (ED<sub>50</sub>) and 95% effective dose (ED<sub>95</sub>) of butorphanol tartrate in patients undergoing painless gastroscopy.</p><p><strong>Methods: </strong>Patients who underwent painless gastroscopy at Binzhou Medical University Hospital were divided into the youth, middle-aged, and older groups. The ED<sub>50</sub> and ED<sub>95</sub> required for successful sedation using butorphanol tartrate were measured using the Dixon up-and-down method in patients in the different age groups. Patients in each group were administered intravenous butorphanol 5 minutes before gastroscopy. Each patient was administered 2 mg/kg propofol. The ED<sub>50</sub> and ED<sub>95</sub> of butorphanol were calculated using probit analysis.</p><p><strong>Results: </strong>In total, 95 patients were included. The ED<sub>50</sub>s of butorphanol in the youth, middle-aged, and older groups were 7.384, 6.657, and 6.364 μg/kg, respectively. The ED<sub>95</sub>s of butorphanol doses in these groups were 9.108, 8.419, and 7.348 μg/kg, respectively.</p><p><strong>Conclusions: </strong>The ED<sub>50</sub> and ED<sub>95</sub> varied among the age groups, indicating that the effective dose decreases with age.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418491/pdf/","citationCount":"0","resultStr":"{\"title\":\"The effective dose of butorphanol tartrate in patients of different ages undergoing painless gastroscopy.\",\"authors\":\"Yaorui Sun, Shujiao Liu, Wenli Si, Quanyi Zhang, Fei Yu, Ming Su, Chao Sun\",\"doi\":\"10.1177/03000605241277689\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study evaluated the 50% effective dose (ED<sub>50</sub>) and 95% effective dose (ED<sub>95</sub>) of butorphanol tartrate in patients undergoing painless gastroscopy.</p><p><strong>Methods: </strong>Patients who underwent painless gastroscopy at Binzhou Medical University Hospital were divided into the youth, middle-aged, and older groups. The ED<sub>50</sub> and ED<sub>95</sub> required for successful sedation using butorphanol tartrate were measured using the Dixon up-and-down method in patients in the different age groups. Patients in each group were administered intravenous butorphanol 5 minutes before gastroscopy. Each patient was administered 2 mg/kg propofol. The ED<sub>50</sub> and ED<sub>95</sub> of butorphanol were calculated using probit analysis.</p><p><strong>Results: </strong>In total, 95 patients were included. The ED<sub>50</sub>s of butorphanol in the youth, middle-aged, and older groups were 7.384, 6.657, and 6.364 μg/kg, respectively. The ED<sub>95</sub>s of butorphanol doses in these groups were 9.108, 8.419, and 7.348 μg/kg, respectively.</p><p><strong>Conclusions: </strong>The ED<sub>50</sub> and ED<sub>95</sub> varied among the age groups, indicating that the effective dose decreases with age.</p>\",\"PeriodicalId\":16129,\"journal\":{\"name\":\"Journal of International Medical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418491/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of International Medical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/03000605241277689\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of International Medical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03000605241277689","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
The effective dose of butorphanol tartrate in patients of different ages undergoing painless gastroscopy.
Objective: This study evaluated the 50% effective dose (ED50) and 95% effective dose (ED95) of butorphanol tartrate in patients undergoing painless gastroscopy.
Methods: Patients who underwent painless gastroscopy at Binzhou Medical University Hospital were divided into the youth, middle-aged, and older groups. The ED50 and ED95 required for successful sedation using butorphanol tartrate were measured using the Dixon up-and-down method in patients in the different age groups. Patients in each group were administered intravenous butorphanol 5 minutes before gastroscopy. Each patient was administered 2 mg/kg propofol. The ED50 and ED95 of butorphanol were calculated using probit analysis.
Results: In total, 95 patients were included. The ED50s of butorphanol in the youth, middle-aged, and older groups were 7.384, 6.657, and 6.364 μg/kg, respectively. The ED95s of butorphanol doses in these groups were 9.108, 8.419, and 7.348 μg/kg, respectively.
Conclusions: The ED50 and ED95 varied among the age groups, indicating that the effective dose decreases with age.
期刊介绍:
_Journal of International Medical Research_ is a leading international journal for rapid publication of original medical, pre-clinical and clinical research, reviews, preliminary and pilot studies on a page charge basis.
As a service to authors, every article accepted by peer review will be given a full technical edit to make papers as accessible and readable to the international medical community as rapidly as possible.
Once the technical edit queries have been answered to the satisfaction of the journal, the paper will be published and made available freely to everyone under a creative commons licence.
Symposium proceedings, summaries of presentations or collections of medical, pre-clinical or clinical data on a specific topic are welcome for publication as supplements.
Print ISSN: 0300-0605